Hanmi acquires approval of combined treatment for ‘prostatic hypertrophy and erectile dysfunction’

Published: 2016-10-25 10:27:43

Updated: 2016-10-25 10:27:43

On the 21^st, Hanmi Pharm(CEO Gwan-Sun Lee) announced approval to commercialize ‘Gugutams Cap(generic name: tamsulosin 0.4mg+tadalafil 5mg)’ that combines substances for benign prostatic hypertrophy and erectile dysfunction from the Ministry of Food and Drug Safety.

As a ETC drug requiring doctor’s prescription, Gugutams Cap is a daily treatment after meal. Hanmi Pharm explained it is the worl...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.